• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN (IRVINE) ONYX AVM; AGENT, INJECTABLE, EMBOLIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN (IRVINE) ONYX AVM; AGENT, INJECTABLE, EMBOLIC Back to Search Results
Model Number 105-7100-060
Device Problem Entrapment of Device (1212)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 11/09/2015
Event Type  Injury  
Manufacturer Narrative
The lot numbers were not reported.The device will not be returned for analysis as it was implanted; therefore the complaint could not be confirmed, and the event cause could not be reliably determined.Based on the reported information, the physician did not control the onyx reflux resulting in onyx retrograde flow over the proximal marker band of the microcatheter 1.5cm detachable tip.Per onyx instruction for use, " do not allow more than 1 cm of the onyx¿ les to reflux back over catheter tip.Angioarchitecture, vasospasm, excessive onyx¿ les reflux, or prolonged injection time may result in difficult catheter removal and potential entrapment." same event as reported in mdr mfr: 2029214-2015-05183.
 
Event Description
Medtronic received information that an apollo catheter was entrapped during onyx procedure.The patient was undergoing a presurgical embolization of brain arteriovenous malformation (bavm) in the anterior circulation.In order to form plugs around the catheter tip, the physician paused multiple times between 30 seconds to 1 minute.The duration of onyx injection was 22 minutes.Two vials of onyx were successfully delivered to the avm nidus.There was some onyx retrograde flow over the marker proximal to the detach zone of the apollo (1.5cm detachable tip).Due to this retrograde flow, the physician experienced difficulties in removing the catheter.The physician tried to applied traction to the catheter wait for 30 seconds to 1 minutes and then tried to pull some more.After 5 minutes trying to remove the catheter, the physician decided to cut the apollo microcatheter at the hub and leave it in the patient because the risk of trying to remove the catheter outweighs the benefit.Additionally, the avm surgery had been scheduled in 2 days.The patient woke up fine after the embolization.Two days post onyx embolization, the avm was resected and the catheter was removed successfully.The patient is doing well with no neurological deficit.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ONYX AVM
Type of Device
AGENT, INJECTABLE, EMBOLIC
Manufacturer (Section D)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer Contact
tricha miles
9775 toledo way
irvine, CA 92618
9498373700
MDR Report Key5266961
MDR Text Key32670937
Report Number2029214-2015-05185
Device Sequence Number1
Product Code MFE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P030004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 11/09/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number105-7100-060
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/09/2015
Initial Date FDA Received12/04/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age00038 YR
-
-